Mrs Linda L Vekasi, MSN- CRNA | |
550 Fort Loudoun Medical Center Drive, Lenoir City, TN 37772-5673 | |
(865) 777-0909 | |
(865) 777-0910 |
Full Name | Mrs Linda L Vekasi |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 30 Years |
Location | 550 Fort Loudoun Medical Center Drive, Lenoir City, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548212632 | NPI | - | NPPES |
4113303 | Other | TN | BLUE CROSS/BLUE SHIELD |
7100100960 | Medicaid | KY | |
P00332284 | Other | TN | RAILROAD MEDICARE PIN |
P00810611 | Other | KY | RAILROAD MEDICARE PIN |
4113303 | Other | TN | BCBS TN |
000000616167 | Other | KY | BLUE CROSS/BLUE SHIELD |
362375 | Medicaid | TN |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Knoxville Gastroenterology Anesthesia Associates, Llc | 8325357155 | 4 |
News Archive
Agilent Technologies Inc. today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.
Breast cancer is one of the most common cancers, affecting up to one in eight women during their lives in Europe, the UK and USA. Large population studies such as the Women's Health Initiative and the Million Women Study have shown that synthetic sex hormones called progestins used in hormone replacement therapy, HRT, and in contraceptives can increase the risk of breast cancers.
Mothers whose first child was taken into care were found to have inadequate or no prenatal care during subsequent pregnancies, according to a study published in CMAJ.
Researchers and data scientists at UT Southwestern Medical Center and MD Anderson Cancer Center have developed an artificial intelligence technique that can identify which cell surface peptides produced by cancer cells called neoantigens are recognized by the immune system.
› Verified 7 days ago
Entity Name | Knoxville Ophthalmology Asc, Llc |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1013997915 PECOS PAC ID: 2668557232 Enrollment ID: O20080306000203 |
News Archive
Agilent Technologies Inc. today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.
Breast cancer is one of the most common cancers, affecting up to one in eight women during their lives in Europe, the UK and USA. Large population studies such as the Women's Health Initiative and the Million Women Study have shown that synthetic sex hormones called progestins used in hormone replacement therapy, HRT, and in contraceptives can increase the risk of breast cancers.
Mothers whose first child was taken into care were found to have inadequate or no prenatal care during subsequent pregnancies, according to a study published in CMAJ.
Researchers and data scientists at UT Southwestern Medical Center and MD Anderson Cancer Center have developed an artificial intelligence technique that can identify which cell surface peptides produced by cancer cells called neoantigens are recognized by the immune system.
› Verified 7 days ago
Entity Name | Foothills Anesthesia Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285873380 PECOS PAC ID: 9335296466 Enrollment ID: O20090407000500 |
News Archive
Agilent Technologies Inc. today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.
Breast cancer is one of the most common cancers, affecting up to one in eight women during their lives in Europe, the UK and USA. Large population studies such as the Women's Health Initiative and the Million Women Study have shown that synthetic sex hormones called progestins used in hormone replacement therapy, HRT, and in contraceptives can increase the risk of breast cancers.
Mothers whose first child was taken into care were found to have inadequate or no prenatal care during subsequent pregnancies, according to a study published in CMAJ.
Researchers and data scientists at UT Southwestern Medical Center and MD Anderson Cancer Center have developed an artificial intelligence technique that can identify which cell surface peptides produced by cancer cells called neoantigens are recognized by the immune system.
› Verified 7 days ago
Entity Name | Knoxville Gastroenterology Anesthesia Associates, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356717227 PECOS PAC ID: 8325357155 Enrollment ID: O20151019001298 |
News Archive
Agilent Technologies Inc. today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.
Breast cancer is one of the most common cancers, affecting up to one in eight women during their lives in Europe, the UK and USA. Large population studies such as the Women's Health Initiative and the Million Women Study have shown that synthetic sex hormones called progestins used in hormone replacement therapy, HRT, and in contraceptives can increase the risk of breast cancers.
Mothers whose first child was taken into care were found to have inadequate or no prenatal care during subsequent pregnancies, according to a study published in CMAJ.
Researchers and data scientists at UT Southwestern Medical Center and MD Anderson Cancer Center have developed an artificial intelligence technique that can identify which cell surface peptides produced by cancer cells called neoantigens are recognized by the immune system.
› Verified 7 days ago
Entity Name | Anesthesia Dynamics Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073001012 PECOS PAC ID: 3779832530 Enrollment ID: O20200801000026 |
News Archive
Agilent Technologies Inc. today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.
Breast cancer is one of the most common cancers, affecting up to one in eight women during their lives in Europe, the UK and USA. Large population studies such as the Women's Health Initiative and the Million Women Study have shown that synthetic sex hormones called progestins used in hormone replacement therapy, HRT, and in contraceptives can increase the risk of breast cancers.
Mothers whose first child was taken into care were found to have inadequate or no prenatal care during subsequent pregnancies, according to a study published in CMAJ.
Researchers and data scientists at UT Southwestern Medical Center and MD Anderson Cancer Center have developed an artificial intelligence technique that can identify which cell surface peptides produced by cancer cells called neoantigens are recognized by the immune system.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Linda L Vekasi, MSN- CRNA 12752 Kingston Pike, Ste E202, Knoxville, TN 37934-0948 Ph: (865) 777-0909 | Mrs Linda L Vekasi, MSN- CRNA 550 Fort Loudoun Medical Center Drive, Lenoir City, TN 37772-5673 Ph: (865) 777-0909 |
News Archive
Agilent Technologies Inc. today introduced the SurePrint G3 Human CGH+SNP microarray platform, an innovative system for simultaneous analysis of chromosomal copy number changes and copy-neutral aberrations. The system allows researchers to study the genetic basis of developmental disorders as well as many cancers.
Breast cancer is one of the most common cancers, affecting up to one in eight women during their lives in Europe, the UK and USA. Large population studies such as the Women's Health Initiative and the Million Women Study have shown that synthetic sex hormones called progestins used in hormone replacement therapy, HRT, and in contraceptives can increase the risk of breast cancers.
Mothers whose first child was taken into care were found to have inadequate or no prenatal care during subsequent pregnancies, according to a study published in CMAJ.
Researchers and data scientists at UT Southwestern Medical Center and MD Anderson Cancer Center have developed an artificial intelligence technique that can identify which cell surface peptides produced by cancer cells called neoantigens are recognized by the immune system.
› Verified 7 days ago
Holly Connor, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1130 Timber Ridge Dr, Lenoir City, TN 37771 Phone: 504-352-7219 | |
Mr. Kenneth Zalewski, MSN- CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 550 Fort Loudoun Medical Center Drive, Lenoir City, TN 37772 Phone: 865-777-0909 Fax: 865-777-0910 | |
Lisa Coble, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 550 Fort Loudoun Medical Center Dr, Lenoir City, TN 37772 Phone: 865-271-6000 | |
Karen Jane Phillips-wilson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 124 Lake Crest Dr, Lenoir City, TN 37772 Phone: 865-986-4405 | |
Samuel L Couillard, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 550 Fort Loudoun Medical Center Dr, Lenoir City, TN 37772 Phone: 952-442-9770 | |
Mr. Paul Roger Backus, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 550 Fort Loudoun Medical Center Drive, Lenoir City, TN 37772 Phone: 865-777-0909 Fax: 865-777-0910 |